XML 18 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Interim Condensed Consolidated Statements Of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income/(Loss)
Total Dolby Laboratories, Inc.
Controlling Interest
Class A Common Stock [Member]
Common Stock
Class A Common Stock [Member]
Additional Paid-In Capital
Beginning balance (in shares) at Sep. 28, 2018   102,000              
Beginning balance at Sep. 28, 2018 $ 2,370,503   $ 66,127 $ 2,313,539 $ (15,832) $ 2,363,936 $ 6,567    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 211,570     211,233   211,233 337    
Other comprehensive loss, net of tax 1,202       1,336 1,336 (134)    
Distributions to controlling interest (1,015)           1,015    
Stock-based compensation expense 59,580   59,580     59,580      
Shares repurchased (in shares)   (4,000)              
Repurchase of common stock (286,512)   (148,972) (137,536)   (286,512)      
Cash dividends declared and paid on common stock (58,318)     (58,318)   (58,318)      
Common stock issued under employee stock plans (in shares)               1,000  
Common stock issued under employee stock plans 45,027   45,026     45,027      
Tax withholdings on vesting of restricted stock (in shares)               0  
Tax withholdings on vesting of restricted stock (21,761)         (21,761)     $ (21,761)
Ending balance (in shares) at Jun. 28, 2019   99,000              
Ending balance at Jun. 28, 2019 2,320,276   0 2,328,918 (14,496) 2,314,521 5,755    
Beginning balance (in shares) at Mar. 29, 2019   100,000              
Beginning balance at Mar. 29, 2019 2,352,857   0 2,361,607 (14,683) 2,347,024 5,833    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 39,637     39,574   39,574 63    
Other comprehensive loss, net of tax 47       187 187 (140)    
Distributions to controlling interest (1)           1    
Stock-based compensation expense 18,863   18,863     18,863      
Shares repurchased (in shares)   (1,000)              
Repurchase of common stock (88,632)   (35,651) (52,980)   (88,632)      
Cash dividends declared and paid on common stock (19,283)     (19,283)   (19,283)      
Common stock issued under employee stock plans (in shares)               0  
Common stock issued under employee stock plans 17,869   17,869     17,869      
Tax withholdings on vesting of restricted stock (in shares)               0  
Tax withholdings on vesting of restricted stock (1,081)         (1,081) 0   (1,081)
Ending balance (in shares) at Jun. 28, 2019   99,000              
Ending balance at Jun. 28, 2019 2,320,276   0 2,328,918 (14,496) 2,314,521 5,755    
Beginning balance (in shares) at Sep. 27, 2019   99,000              
Beginning balance at Sep. 27, 2019 2,313,030   0 2,327,877 (20,625) 2,307,351 5,679    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 204,643     204,534   204,534 109    
Other comprehensive loss, net of tax 3,529       3,504 3,504 25    
Distributions to controlling interest (283)           (283)    
Stock-based compensation expense $ 64,850   64,850     64,850      
Shares repurchased (in shares) (1,921,863) (2,000)              
Repurchase of common stock $ (128,753)   (111,168) (17,583)   (128,753)      
Cash dividends declared and paid on common stock (66,439)     (66,439)   (66,439)      
Common stock issued under employee stock plans 68,289 $ 2 68,287     68,289      
Tax withholdings on vesting of restricted stock (21,969)         (21,969)     (21,969)
Ending balance (in shares) at Jun. 26, 2020   99,000              
Ending balance at Jun. 26, 2020 2,436,897   0 2,448,389 (17,121) 2,431,367 5,530    
Beginning balance (in shares) at Mar. 27, 2020   99,000              
Beginning balance at Mar. 27, 2020 2,369,277   0 2,395,575 (31,615) 2,364,059 5,218    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 67,378     67,285   67,285 93    
Other comprehensive loss, net of tax 14,713       14,494 14,494 219    
Stock-based compensation expense 21,285   21,285     21,285      
Shares repurchased (in shares)   (1,000)              
Repurchase of common stock (27,081)   (34,712) 7,632   (27,081)      
Cash dividends declared and paid on common stock (22,103)     (22,103)   (22,103)      
Common stock issued under employee stock plans 14,303 $ 1 14,302     14,303      
Tax withholdings on vesting of restricted stock (875)       0 (875) 0   $ (875)
Ending balance (in shares) at Jun. 26, 2020   99,000              
Ending balance at Jun. 26, 2020 $ 2,436,897   $ 0 $ 2,448,389 $ (17,121) $ 2,431,367 $ 5,530